Mirae Asset Global ETFs Holdings

Mirae Asset Global ETFs Holdings’s Larimar Therapeutics LRMR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$104K	Buy	23,091 +544	+2%	+$2.17K	﹤0.01%	2650
2025 Q4	$85.9K	Buy	22,547 +704	+3%	+$2.74K	﹤0.01%	2737
2025 Q3	$70.6K	Sell	21,843 -2,274	-9%	-$8.53K	﹤0.01%	2828
2025 Q2	$69.7K	Sell	24,117 -1,092	-4%	-$2.53K	﹤0.01%	2775
2025 Q1	$54.2K	Buy	25,209 +1,092	+5%	+$3.45K	﹤0.01%	2835
2024 Q4	$93.3K	Buy	24,117 +1,064	+5%	+$7.02K	﹤0.01%	2732
2024 Q3	$151K	Buy	23,053 +10,037	+77%	+$80.7K	﹤0.01%	2511
2024 Q2	$94.4K	Buy	+13,016	New	+$99.7K	﹤0.01%	2587

Other funds holding LRMR

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return